tiprankstipranks
Trending News
More News >
CStone Pharmaceuticals (HK:2616)
:2616
Hong Kong Market
Advertisement

CStone Pharmaceuticals (2616) Similar Stocks

Compare
3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
CStone Pharmaceuticals
HK$7.73
HK$10.76B
296.41%
1 Buy
0 Hold
0 Sell
Moderate Buy
Alphamab Oncology
HK$13.09
HK$11.95B
46.78
177.33%
0 Buy
0 Hold
0 Sell
Hold
HBM Holdings Ltd.
HK$14.52
HK$12.81B
19.65
908.33%
1 Buy
0 Hold
0 Sell
Moderate Buy
Jiangsu Recbio Technology Co., Ltd. Class H
HK$7.58
HK$3.64B
-6.30%
0 Buy
0 Hold
0 Sell
Hold
Abbisko Cayman Limited
HK$17.50
HK$11.53B
60.56
353.37%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$12.54
HK$7.80B
202.91
26.70%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2616
CStone Pharmaceuticals
7.73
5.78
296.41%
HK:9966
Alphamab Oncology
13.09
8.37
177.33%
HK:2142
HBM Holdings Ltd.
14.52
13.08
908.33%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
7.58
-0.51
-6.30%
HK:2256
Abbisko Cayman Limited
17.50
13.64
353.37%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
12.67
2.67
26.70%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis